Goldman Sachs’s MiMedx Group MDXG Stock Holding History

Goldman Sachs’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-305,000	Closed	-$2.13M	–	5853
2018 Q1	$2.13M	Buy	305,000 +298,300	+4,452%	+$3.47M	﹤0.01%	3564
2017 Q4	$84K	Buy	6,700 +2,900	+76%	+$35.4K	﹤0.01%	5802
2017 Q3	$45K	Sell	3,800 -41,800	-92%	-$620K	﹤0.01%	6273
2017 Q2	$683K	Buy	45,600 +26,900	+144%	+$359K	﹤0.01%	4813
2017 Q1	$178K	Buy	+18,700	New	+$158K	﹤0.01%	5796
2016 Q3	–	Sell	-500	Closed	-$4K	–	7117
2016 Q2	$4K	Sell	500 -49,700	-99%	-$387K	﹤0.01%	6943
2016 Q1	$439K	Sell	50,200 -9,800	-16%	-$81.4K	﹤0.01%	4872
2015 Q4	$562K	Hold	60,000	–	–	﹤0.01%	4823
2015 Q3	$579K	Sell	60,000 -3,900	-6%	-$41.2K	﹤0.01%	4996
2015 Q2	$741K	Sell	63,900 -700	-1%	-$7.2K	﹤0.01%	4820
2015 Q1	$672K	Buy	+64,600	New	+$605K	﹤0.01%	4840
2014 Q4	–	Sell	-328,000	Closed	-$2.34M	–	7230
2014 Q3	$2.34M	Buy	328,000 +79,000	+32%	+$551K	﹤0.01%	3785
2014 Q2	$1.76M	Buy	+249,000	New	+$1.46M	﹤0.01%	4117

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Goldman Sachs's MDXG Position: Q1 2026 in Review

Goldman Sachs increased its MiMedx Group (MDXG) stake by 8.7% in Q1 2026, buying an estimated $479K and bringing the position to 1,185,561 shares worth $4.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3769.

Goldman Sachs first reported a position in MDXG in Q2 2013 and has held it in 44 quarters since. The position peaked at $9.84M in Q3 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

Goldman Sachs held 1,185,561 shares of MiMedx Group worth $4.68M as of Q1 2026.
Goldman Sachs bought 95,176 MiMedx Group shares in Q1 2026, an estimated $479K.
MiMedx Group made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3769 holding.
Goldman Sachs first reported a position in MiMedx Group in Q2 2013 and has held it in 44 quarters since.
Goldman Sachs's MiMedx Group position peaked at $9.84M in Q3 2017.
237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.